A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58
Open Access
- 1 January 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 55 (1), 115-118
- https://doi.org/10.1093/jac/dkh500
Abstract
Objective: The aim of this study was to analyse the spread of the blaOXA-58 gene as a source of carbapenem resistance in Acinetobacter baumannii in the burns unit of a university hospital in Toulouse in 2003–2004. Methods: Six carbapenem-resistant A. baumannii isolates from six patients, and a carbapenem-resistant environmental A. baumannii isolate were collected in the burns unit of the Rangueil hospital (Toulouse). Susceptibility tests were carried out by disc diffusion and agar dilution methods. The detection of the blaOXA-58 gene was conducted by PCR followed by sequence analysis. Plasmids were extracted and hybridized with a probe specific for blaOXA-58. DNA fingerprints were obtained by pulsed-field gel electrophoresis of ApaI- or SmaI-digested chromosomal DNA of the tested strains. Results: The multidrug-resistant clinical isolates had a similar 30 kb plasmid that encoded the carbapenem-hydrolysing β-lactamase OXA-58. These isolates were clonally related. The unrelated environmental carbapenem-resistant A. baumannii isolate had a similar blaOXA-58-carrying plasmid, suggesting spread of this gene. Conclusions: A novel oxacillinase was the source of carbapenem resistance in the A. baumannii isolates. Its gene was plasmid-, but not integron-borne.Keywords
This publication has 12 references indexed in Scilit:
- OXA-58, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems inAcinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2005
- Outbreak of Carbapenem-Resistant Acinetobacter baumannii Producing the OXA-23 Enzyme in Curitiba, BrazilJournal of Clinical Microbiology, 2003
- Genetic and Functional Analysis of the Chromosome-Encoded Carbapenem-Hydrolyzing Oxacillinase OXA-40 ofAcinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2003
- Endemic Carbapenem Resistance Associated with OXA-40 Carbapenemase among Acinetobacter baumannii Isolates from a Hospital in Northern SpainJournal of Clinical Microbiology, 2002
- Acquired Carbapenem-Hydrolyzing Beta-Lactamases and their Genetic SupportCurrent Pharmaceutical Biotechnology, 2002
- Characterization of OXA-25, OXA-26, and OXA-27, Molecular Class D β-Lactamases Associated with Carbapenem Resistance in Clinical Isolates of Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2001
- OXA-24, a Novel Class D β-Lactamase with Carbapenemase Activity in an Acinetobacter baumannii Clinical StrainAntimicrobial Agents and Chemotherapy, 2000
- OXA-Type β-LactamasesCurrent Pharmaceutical Design, 1999
- Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological featuresClinical Microbiology Reviews, 1996
- Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coliPlasmid, 1984